José C. Díaz‐Maqueo

733 total citations
34 papers, 529 citations indexed

About

José C. Díaz‐Maqueo is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, José C. Díaz‐Maqueo has authored 34 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 8 papers in Genetics. Recurrent topics in José C. Díaz‐Maqueo's work include Lymphoma Diagnosis and Treatment (28 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). José C. Díaz‐Maqueo is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). José C. Díaz‐Maqueo collaborates with scholars based in Mexico, Russia and Vietnam. José C. Díaz‐Maqueo's co-authors include Edna L. García, Alejandra Talavera, Renaldo Guzmán, Agustín Avilés, Agustin Avilés, Judith Huerta‐Guzmán, Serafín Delgado, M. Jesús Nambo, Natividad Neri and María Teresa Rugeles López and has published in prestigious journals such as European Journal of Cancer, American Journal of Hematology and Investigational New Drugs.

In The Last Decade

José C. Díaz‐Maqueo

33 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José C. Díaz‐Maqueo Mexico 12 294 261 98 89 89 34 529
Caroline Kuhlman United States 8 301 1.0× 338 1.3× 135 1.4× 65 0.7× 99 1.1× 12 596
F. B. Hagemeister United States 10 329 1.1× 304 1.2× 56 0.6× 82 0.9× 45 0.5× 25 564
Edna L. García Mexico 12 287 1.0× 230 0.9× 38 0.4× 63 0.7× 87 1.0× 29 473
DP Deakin United Kingdom 7 549 1.9× 222 0.9× 170 1.7× 80 0.9× 94 1.1× 9 714
Renaldo Guzmán Mexico 12 313 1.1× 254 1.0× 29 0.3× 94 1.1× 86 1.0× 20 485
E.‐W. Schwarze Germany 13 124 0.4× 284 1.1× 61 0.6× 89 1.0× 113 1.3× 37 470
Dan Painter United Kingdom 6 180 0.6× 251 1.0× 68 0.7× 60 0.7× 98 1.1× 10 460
Irfan Maghfoor Saudi Arabia 12 320 1.1× 223 0.9× 73 0.7× 106 1.2× 55 0.6× 43 526
Murphy Sb United States 7 237 0.8× 470 1.8× 145 1.5× 189 2.1× 284 3.2× 10 695
Judith Huerta‐Guzmán Mexico 17 400 1.4× 400 1.5× 133 1.4× 116 1.3× 26 0.3× 42 666

Countries citing papers authored by José C. Díaz‐Maqueo

Since Specialization
Citations

This map shows the geographic impact of José C. Díaz‐Maqueo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José C. Díaz‐Maqueo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José C. Díaz‐Maqueo more than expected).

Fields of papers citing papers by José C. Díaz‐Maqueo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José C. Díaz‐Maqueo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José C. Díaz‐Maqueo. The network helps show where José C. Díaz‐Maqueo may publish in the future.

Co-authorship network of co-authors of José C. Díaz‐Maqueo

This figure shows the co-authorship network connecting the top 25 collaborators of José C. Díaz‐Maqueo. A scholar is included among the top collaborators of José C. Díaz‐Maqueo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José C. Díaz‐Maqueo. José C. Díaz‐Maqueo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avilés, Agustín, José Luis González, Edna L. García, et al.. (2002). Spinal Cord Compression as a Primary Manifestation of Aggressive Malignant Lymphomas: Long-term Analysis of Treatments with Radiotherapy, Chemotherapy or Combined Therapy. Leukemia & lymphoma. 43(2). 355–359. 12 indexed citations
2.
Neri, Natividad, Agustín Avilés, Sergio Cleto, et al.. (2001). Chemotherapy Plus Interferon- α 2b Versus Chemotherapy in the Treatment of Follicular Lymphoma. Journal of Hematotherapy & Stem Cell Research. 10(5). 669–674. 5 indexed citations
3.
Avilés, Agustín, et al.. (2001). Rituximab in the Treatment of Refractory Follicular Lymphoma - Six Doses Are Better Than Four. Journal of Hematotherapy & Stem Cell Research. 10(2). 313–316. 11 indexed citations
4.
Avilés, Agustín, José C. Díaz‐Maqueo, Edna L. García, et al.. (2001). Late Lethal Events in Patients with Diffuse Large B Cell Lymphoma: a Review of 714 Patients Treated in a Single Centre. Leukemia & lymphoma. 42(4). 631–637. 6 indexed citations
5.
Avilés, Agustín, et al.. (1999). High Dose Chemotherapy with G-CSF in Refractory Hodgkin's Disease. Leukemia & lymphoma. 36(1-2). 139–145. 2 indexed citations
6.
7.
Avilés, Agustín, José C. Díaz‐Maqueo, Alejandra Talavera, et al.. (1997). Bone marrow protection with amifostine in the treatment of high-risk malignant lymphoma. European Journal of Cancer. 33(8). 1323–1325. 18 indexed citations
8.
Avilés, Agustín, Renaldo Guzmán, Edna L. García, & José C. Díaz‐Maqueo. (1996). Biological Modifiers (Etetrinate and Interferon Alfa 2a) in the Treatment of Refractory Cutaneous T-Cell Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 11(1). 21–24. 14 indexed citations
9.
Avilés, Agustin, Renaldo Guzmán, Serafín Delgado, et al.. (1996). Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma. American Journal of Hematology. 52(4). 275–280. 10 indexed citations
10.
Bezwoda, W. R., R.B. Rastogi, A Valla, et al.. (1995). Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas. European Journal of Cancer. 31(6). 903–911. 22 indexed citations
11.
Avilés, Agustin, et al.. (1995). GM-CSF Instead of Hematological Support During High-Dose Chemotherapy for Refractory Malignant Lymphoma. Leukemia & lymphoma. 17(3-4). 327–330. 8 indexed citations
12.
Avilés, Agustín, José C. Díaz‐Maqueo, Alejandra Talavera, M. Jesús Nambo, & Edna L. García. (1994). Effect of Granulocyte Colony-Stimulating Factor in Patients with Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy. Leukemia & lymphoma. 15(1-2). 153–157. 14 indexed citations
13.
Avilés, Agustín, et al.. (1993). Value of Serum Beta 2 Microglobulin as an Indicator of Early Relapse in Diffuse Large Cell Lymphoma. Leukemia & lymphoma. 9(4-5). 377–380. 11 indexed citations
14.
Avilés, Agustín, et al.. (1992). Beta 2 Microglobulin Level as an Indicator of Prognosis in Diffuse Large Cell Lymphoma. Leukemia & lymphoma. 7(1-2). 135–138. 17 indexed citations
15.
Avilés, Agustín, et al.. (1992). Angiocentric T‐cell lymphoma of the nose, paranasal sinuses and hard palate. Hematological Oncology. 10(3-4). 141–147. 29 indexed citations
16.
Díaz‐Maqueo, José C., et al.. (1992). Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma. Investigational New Drugs. 10(4). 351–355. 21 indexed citations
17.
Díaz‐Maqueo, José C., et al.. (1991). [CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas].. PubMed. 42(4). 271–6. 2 indexed citations
18.
Avilés, Agustín, et al.. (1991). Is Surgery Necessary in the Treatment of Primary Gastric Non-Hodgkin Lymphoma?. Leukemia & lymphoma. 5(5-6). 365–369. 29 indexed citations
19.
Avilés, Agustín, et al.. (1991). Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma. Hematological Oncology. 9(2). 115–121. 6 indexed citations
20.
Avilés, Agustín, et al.. (1989). Neoplasias hematologicas y embarazo. 117–120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Kuhlman Breakdown of academic impact, for papers by F. B. Hagemeister Breakdown of academic impact, for papers by Edna L. García Breakdown of academic impact, for papers by DP Deakin Breakdown of academic impact, for papers by Renaldo Guzmán Breakdown of academic impact, for papers by E.‐W. Schwarze Breakdown of academic impact, for papers by Dan Painter Breakdown of academic impact, for papers by Irfan Maghfoor Breakdown of academic impact, for papers by Murphy Sb Breakdown of academic impact, for papers by Judith Huerta‐Guzmán
Rankless by CCL
2026